The landscape of treatment of blood cancers with FLT3 positive mutations by novel inhibitory therapeutics is massively growing, with many emerging and legacy companies venturing into the industry with their respective therapeutic portfolio exclusively developed and designed for the treatment of FLT3 mutated acute myeloid leukemia (AML). Through imaging, genetic, and biomarker studies, researchers are gaining a deeper understanding of the biology of AML, which will likely resolve many current problems in FLT3 mutated AML diagnosis and classification.

Bioreactors are vessels that are used to manufacture biologics and biosimilars such as peptides, antibodies, vaccines, and pharmaceuticals (using plant or animal cells). Fermenters are used to manufacture acids and alcohols through the fermentation of microbes. Single-use bioreactors and fermenters have witnessed a considerable surge in popularity as they meet the demands of the biopharmaceutical industry and offer higher efficiency and greater flexibility at lower costs. For instance, single-use bioreactors and fermenters are pre-sterilized and can be disposed of after use, which minimizes the chances of cross-contamination.

Serum-free media is medium type that enables cell culture to be carried out under a controlled set of conditions. There is no requirement of supplementation of serum in the serum-free media as it does not comprise any sort of animal/human serum/plasma as primary components. Some common forms of commercialized serum-free media are xeno-free media, common serum-free media, and chemically-defined media formulations for cell therapy. Companies like STEMCELL Technologies, Lonza Group AG, and Thermo Fisher Scientific Inc. manufacture small molecules as media supplements and they are generally easily available, chemically defined, and tunable.

There is significant growth in the global micropropagation market due to continuous R&D investments in technological innovation and advanced techniques to increase crop efficiency and quality in agriculture. Micropropagation is used to produce crops that are difficult to propagate using conventional methods, such as seeding or cutting. Moreover, micropropagation helps to create many progeny plants using modern plant tissue culture methods.

Novel time-lapse microscopy technologies enable the image analysis of living cells, fresh tissues, or live-in vivo models in a time-resolved manner. The imaging of live cells is done to monitor internal cellular structures, processes, and interactions to determine drug efficacy, safety, and actions reliably. It helps determine whether drugs bind to the intended target or have any off-target effects.